Skip to content

KALA BIO, Inc.

KALA

CIK 0001479419

← back to feed
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$29.29M
+29.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$73.41
+67.4% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$40.3M
Q1 May 2026
Cash
$1.76M
Q1 May 2026
Total Debt
$47.2M
Q1 May 2026
Shares Outstanding
18.59M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings